跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PRIVA-AMITRIPTYLINE
Authorized
STANDARD
PRIVA-AMITRIPTYLINE
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
95caa3cdedc90838
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
95caa3cdedc90838
Drug Approval Canada Name
PRIVA-AMITRIPTYLINE
Product Name
PRIVA-AMITRIPTYLINE
Status
Cancelled Post Market
Status Date
2022-10-01
Original Market Date
2020-02-25
Din
02490145
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.28
Atc Original
N06AA09 AMITRIPTYLINE
Atc Name
n 06 aa 09
Aig Number
0101524004
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
AMITRIPTYLINE HYDROCHLORIDE
75 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
95caa3cdedc90838
Type
Standard
Back to Health Canada Approvals
PRIVA-AMITRIPTYLINE - Health Canada Drug Approval Details